Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Calvez

Showing results (111-120 of 329) with videos related to

Pageof 33
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 31, 2005
Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophyMarc Buffet, Michaël Schwarzinger, Bahia Amellal, et al.
AIDS (London, England)|December 4, 2008
Antiretroviral combinations implicated in emergence of the L74I and L74V resistance mutations in HIV-1-infected patientsMarc Wirden, Sidonie Lambert-Niclot, Anne-Genevieve Marcelin, et al.
The Journal of Antimicrobial Chemotherapy|January 17, 2009
Mutations associated with virological response to darunavir/ritonavir in HIV-1-infected protease inhibitor-experienced patientsDiane Descamps, Sidonie Lambert-Niclot, Anne-Geneviève Marcelin, et al.
The Journal of Antimicrobial Chemotherapy|February 13, 2010
Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonistsCathia Soulié, Slim Fourati, Sidonie Lambert-Niclot, et al.
The Journal of Infection|August 1, 2006
Association of Gag cleavage sites to protease mutations and to virological response in HIV-1 treated patientsIsabelle Malet, Bénédicte Roquebert, Cécile Dalban, et al.
The Journal of Antimicrobial Chemotherapy|November 26, 2009
Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in MaliDavid Germanaud, Anne Derache, Mamadou Traore, et al.
Infectious Diseases Now|February 17, 2025
Clinical, biological, metabolic, and immune changes associated with the use of sodium-glucose cotransporter 2 inhibitors in people living with HIVVincent Guiraud, Delphine Sauce, Randa Bittar, et al.
Journal of Medical Virology|September 5, 2002
Kaposi's sarcoma herpesvirus and HIV-1 seroprevalences in prostitutes in DjiboutiAnne-Geneviève Marcelin, Marc Grandadam, Philippe Flandre, et al.
The Journal of Antimicrobial Chemotherapy|June 17, 2011
Improved V3 genotyping with duplicate PCR amplification for determining HIV-1 tropismStéphanie Raymond, Patricia Recordon-Pinson, Adrien Saliou, et al.
The Journal of Infectious Diseases|October 24, 2007
Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated diseaseAnne-Geneviève Marcelin, Jérome Motol, Amélie Guihot, et al.
Pageof 33

Showing results (111-120 of 329) with videos related to

Sort By:
Pageof 33
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 31, 2005
Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophyMarc Buffet, Michaël Schwarzinger, Bahia Amellal, et al.
AIDS (London, England)|December 4, 2008
Antiretroviral combinations implicated in emergence of the L74I and L74V resistance mutations in HIV-1-infected patientsMarc Wirden, Sidonie Lambert-Niclot, Anne-Genevieve Marcelin, et al.
The Journal of Antimicrobial Chemotherapy|January 17, 2009
Mutations associated with virological response to darunavir/ritonavir in HIV-1-infected protease inhibitor-experienced patientsDiane Descamps, Sidonie Lambert-Niclot, Anne-Geneviève Marcelin, et al.
The Journal of Antimicrobial Chemotherapy|February 13, 2010
Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonistsCathia Soulié, Slim Fourati, Sidonie Lambert-Niclot, et al.
The Journal of Infection|August 1, 2006
Association of Gag cleavage sites to protease mutations and to virological response in HIV-1 treated patientsIsabelle Malet, Bénédicte Roquebert, Cécile Dalban, et al.
The Journal of Antimicrobial Chemotherapy|November 26, 2009
Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in MaliDavid Germanaud, Anne Derache, Mamadou Traore, et al.
Infectious Diseases Now|February 17, 2025
Clinical, biological, metabolic, and immune changes associated with the use of sodium-glucose cotransporter 2 inhibitors in people living with HIVVincent Guiraud, Delphine Sauce, Randa Bittar, et al.
Journal of Medical Virology|September 5, 2002
Kaposi's sarcoma herpesvirus and HIV-1 seroprevalences in prostitutes in DjiboutiAnne-Geneviève Marcelin, Marc Grandadam, Philippe Flandre, et al.
The Journal of Antimicrobial Chemotherapy|June 17, 2011
Improved V3 genotyping with duplicate PCR amplification for determining HIV-1 tropismStéphanie Raymond, Patricia Recordon-Pinson, Adrien Saliou, et al.
The Journal of Infectious Diseases|October 24, 2007
Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated diseaseAnne-Geneviève Marcelin, Jérome Motol, Amélie Guihot, et al.
Pageof 33